A CLINICAL STUDY INVESTIGATING THE EFFICACY, TOLERABILITY, AND SAFETY OF CONTINUOUS SUBCUTANEOUS ND0612 INFUSION GIVEN AS ADJUNCT TREATMENT TO ORAL LEVODOPA IN PATIENTS WITH PARKINSON'S DISEASE WITH MOTOR FLUCTUATIONS: